SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to a fresh 52-week high ahead of its Q3 results is driving attention, alongside bullish options activity and expectations for continued BRIUMVI growth. Traders are also speculating about a potential buyout or short squeeze, though others caution that the run may already reflect strong earnings expectations and that no deal is confirmed.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA submission for sonelokimab in hidradenitis suppurativa has traders focused on whether the FDA will accept it for review and grant priority review. Bulls see regulatory progress and the drugs potential as support, while skeptics worry about approval risk, a go-it-alone launch, and possible future dilution without a partnership or buyout.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owls Q3 earnings beat expectations, and traders are focusing on stronger fee-related earnings, dividend coverage, and future fees from uninvested capital. The reaction is bullish, though concerns about private-credit redemptions persist and options activity suggests traders remain divided.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

ARM is selling off with semiconductor peers, with traders linking the decline to Intels weak outlook and broader chip-sector pressure while questioning ARMs rich valuation. Dip buyers counter that AI-driven CPU demand supports the long-term story, with earnings approaching.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,811.032761 with 281,866,747.320393 in circulation. The last known price of OFFICIAL TRUMP is 1.57555883 USD and is down -1.93 over the last 24 hours. It is currently trading on 744 active market(s) with $126,884,732.61 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

Discussion centers on the TRUMP meme coins steep decline, with many traders calling it a cash grab and lamenting losses while others expect a speculative rebound. Election-related speculation adds to the polarized bull-versus-bear debate, but no confirmed new catalyst dominates.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm is drawing attention ahead of its fiscal Q1 earnings report, with traders weighing expectations for continued GMV and revenue growth against concerns about high rates, consumer credit quality, and valuation. The community is split between bulls expecting another strong update and bears warning that macro pressure could weigh on the BNPL lender.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

Bitwise XRP ETF is drawing attention amid volatile XRP trading, with traders pointing to ETF inflows and possible regulatory clarity as supportive themes. Optimism about institutional demand contrasts with frustration over losses and confusion between the ETF shares and XRP itself.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Stockholm, Sweden.

Spotify Technology S.A.

Spotify shares are drawing attention after rising on Q3 results and an upbeat Q4 profit outlook, with premium subscriber growth and stronger gross margin outweighing a revenue and EPS miss for many traders. The reaction is split: bulls focus on the guidance and user momentum, while skeptics question the rally amid rising expenses and valuation concerns.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is drawing attention as natural-gas weakness and repeated lows weigh on the leveraged ETF, with traders citing mild winter forecasts, storage builds and losses from futures rolling and daily leverage. Some are buying for a possible cold-weather or polar-vortex rebound, while bears argue that oversupply and fund decay remain headwinds.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter results, which topped analyst expectations on growth from Dupixent and Eylea HD, have driven a sharp rally and a new 52-week high. Traders are broadly upbeat about the companys growth across multiple drugs, while some caution that declining legacy Eylea sales remain a risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

USO is drawing attention as Iran-related conflict and threats to shipping through the Strait of Hormuz stoke fears of oil-supply disruption and support crude prices. Traders are divided between bulls betting on further escalation and bears expecting diplomacy or a ceasefire to unwind the geopolitical risk premium.

Exxon CEO Says Diesel Is The ‘Key Crunch Point’ In Global Fuel Shortage – Oil Giant To Continue Investing ‘Several Billion Dollars’ In Refineries

Equity

In an interview with CNBC, CEO Darren Woods noted that crude oil supplies have somewhat recovered, but refining capacity remains the biggest constraint, limiting the availability of diesel and other refined products.


Fed Likely To Hold Rates Steady, Says Wolfe Research’s Roth — Analysts See Inflation Risks Keeping December Hike In Play

Hotter September inflation, rising oil prices and a 10-year Treasury yield above 5% are complicating the Fed’s outlook.

Rubio Calls Trump's Russia Diesel Deal 'Very Wise' Amid Soaring Prices — Russian Deputy PM Says Ready To Supply 'As Much As Our Partners Want'

According to a report by German news outlet N-TV, Rubio said the move reflects the broader economic impact of conflicts disrupting energy markets.

Goldman Sachs Says Refiners See 'High Probability' Of Sharp Oil Supply Drop As Houthi Attacks Escalate — Crude Oil Prices Hit 6-Month High

Goldman Sachs' co-head of Global Commodities Research and head of Oil Research, Daan Struyven, said the recent rise in crude prices reflects growing downside risks to supply.

S&P 500, Dow Drop As Elevated Oil Prices Stoke Inflation Fears Ahead Of Fed Meeting Next Week — AAPL, AXP, CART, UBER In Focus

Brent crude rose 3.1% to end the session at $116.72 a barrel, the highest level since April. 


USO Jumps To Over 11-Year High As Brent Tops $116, WTI Crosses $100 Amid Escalating Middle East Tensions

Brent crude futures reached a six-month high on Friday as attacks on Saudi Arabia and concerns over further Middle East escalation fueled fears of oil supply disruptions.

Stocktwits Midweek Energy Roundup: Brent Crosses $110 A Barrel, Musk’s Comments On Power For AI, Key Earnings Check

Oil prices have surged as concerns over Middle East supplies mount, with Brent crude breaching $110 a barrel and U.S. West Texas Intermediate rising to about $99.

Energy ETFs: How to Play the Sector's Surge

 Here is where investors are finding the biggest opportunities across the oil value chain.

S&P 500 Could Hit 8,300 By May 2027, Says Morgan Stanley Investment Chief Predicting ‘Final Innings’ Of Stock Market Correction

In an interview with CNBC, Morgan Stanley’s chief investment officer said he expects market volatility to persist for another two to three weeks.


USO, UCO Gain Premarket As Brent Crude Hits 5-Month High — Middle East Shipping Attacks Fuel Supply Fears

Capital Economics commodities economist Hamad Hussain warned that escalating attacks on ships could trigger a renewed fall in oil supply and continued price rises.

United States Oil Fund LP - United States Oil Fund

Bearish Sentiment

<ul class="summary-bullets"><li>Woods said Exxon’s refineries are operating at record utilization levels and diesel yields are at record highs.</li><li>Expects to increase distillate throughput by about 100,000 barrels a day, Woods added.</li><li>Exxon reported Q3 revenue of $113.16 billion, beating analyst estimate of $105.24 billion, according to Fiscal.ai</li></ul>ExxonMobil (XOM) CEO Darren Woods said on Friday that global diesel supplies remain under severe pressure as geopolitical conflicts disrupt refining operations and fuel shipments, driving prices higher.In an interview with CNBC, Woods said Exxon is operating its refineries at record levels to maximize fuel production amid tight global supplies.“And frankly, diesel is the key crunch point here, because it is so critical to economic growth. Demand for diesel remains high despite capacity,” Woods said, adding that Exxon has focused heavily on maximizing refinery throughput, with refineries operating at record utilization levels and diesel yields reaching record highs.<a class="mention" data-mention="$XOM" data-symbol-id="XOM" href="https://stocktwits.com/symbol/XOM" target="_blank">XOM shares</a> were up 1.9% at the time of writing, hitting an all-time high.<h2 class="st-heading-2">Exxon To Continue Investing Billions In Refineries</h2>Woods pointed to the closure of the Strait of Hormuz amid the U.S.-Israel war with Iran, along with Ukrainian attacks on Russian refineries, as major disruptions to global fuel supplies.“Refining capacity is very tight today,” Woods said, adding that while crude oil supplies have somewhat recovered, refining capacity remains the biggest constraint, limiting the availability of diesel and other refined products.Woods said Exxon will continue to invest “several billion dollars” in refineries to get more diesel out into the marketplace. “Our expectation is, we’re going to increase distillate throughput by about 100,000 barrels a day, as we go forward,” Woods said.Exxon <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investor.exxonmobil.com/company-information/press-releases/detail/1213/exxonmobil-announces-third-quarter-2026-results">reported</a> third-quarter (Q3) revenue of $113.16 billion, beating Wall Street estimates of $105.24 billion, according to Fiscal.ai. Adjusted earnings per share reached $4.23, exceeding expectations of $4.04. The company also declared a dividend of $1.07 per share, payable December 10.Exxon’s peer Chevron (CVX) also posted an earnings beat earlier in the day.<h2 class="st-heading-2">Retail Remains Bullish On XOM</h2>Retail sentiment surrounding XOM on Stocktwits remained ‘bullish’ over the past 24 hours.XOM shares are up more than 53% so far in 2026.Also read:<a href="https://stocktwits.com/news-articles/markets/equity/astra-zeneca-ceo-sees-over-20b-potential-from-2027-drug-trial-readouts-azn-stock-eyes-breakout/cZUhAwOR9Th">&nbsp;AstraZeneca CEO Sees Over $20B Potential From 2027 Drug Trial Readouts – AZN Stock Eyes Breakout After Q3 Earnings Beat</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The ExxonMobil company logo is displayed as traders work on the floor of the New York Stock Exchange during morning trading on May 30, 2023.

In an interview with CNBC, CEO Darren Woods noted that crude oil supplies have somewhat recovered, but refining capacity remains the biggest constraint, limiting the availability of diesel and other refined products.

Chevron Corp.

ProShares Ultra Bloomberg Crude Oil

United States Oil Fund

Exxon Mobil Corp

Broad Domestic Equity

Broad International Equity

Sector / Thematic Equity

Private Markets

Which type of ETFs are you interested in? 
 
*Sponsored by Calamos and S&amp;P Global

Stocktwits

Which type of ETFs are you interested in? 
 
*Sponsored by Calamos and S&P Global

Stocktwits Polls

Market participants are weighing the potential impact of US-Iran diplomatic talks against lingering fears of military conflict.

Feed

News

Sentiment

Fundamentals

Info

USO News